Drug
Velmanase alfa clinical trials
Also written Lamazym and rhLAMAN.
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Studies
Open first, then newest update. How each study uses velmanase alfa is read from its arms, and is right about nine times in ten.
Testing it · 9
- Lamazym Aftercare Study FR Designed to Provide Treatment for French PatientsCompletedPhase 3Chiesi Farmaceutici S.p.A.NCT01908712Written as Lamazym
- Lamazym Aftercare StudyCompletedPhase 3Chiesi Farmaceutici S.p.A.NCT01908725Written as Lamazym
- Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-MannosidosisCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT02998879Written as Velmanase Alfa (e.g. Lamazym)
- Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha MannosidosisWithdrawnPhase 3Chiesi Farmaceutici S.p.A.NCT04031066Written as Velmanase Alfa
- Evaluation of Long-term Efficacy of Treatment With LamazymCompletedPhase 3Zymenex A/SNCT02478840Written as Lamazym
- Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosisCompletedPhase 1Zymenex A/SNCT01268358Written as Lamazym
- A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-MannosidosisCompletedPhase 3Zymenex A/SNCT01681953Written as Lamazym
- Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-MannosidosisCompletedPhase 2Zymenex A/SNCT01681940Written as Lamazym
- Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosisStatus unknownPhase 2Zymenex A/SNCT01285700Written as Lamazym
Codes
What other systems call velmanase alfa · ClinicalTrials.gg INT002164
- MeSH (NLM) C000731931velmanase-alfaOne source NLM
- UNII (FDA) M91TG242P2VELMANASE ALFAConfirmed FDA, NLM, Wikidata
- Wikidata Q98651803velmanase alfaConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152849Velmanase AlfaOne source FDA
- DrugBank DB12374One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000731931 | velmanase-alfa | One source NLM |
| UNII (FDA) | M91TG242P2 | VELMANASE ALFA | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q98651803 | velmanase alfa | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152849 | Velmanase Alfa | One source FDA |
| DrugBank | DB12374 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.